September 2013 Vol. 5 Issue 9

Abstracts & Commentary

Calcium Channel Blocker Use and Breast Cancer Risk

By Tina Kaczor, ND, FABNO
With 1 in 3 Americans having high blood pressure, antihypertensive drugs are among the most frequently prescribed medicines in America. There are 11 different antihypertensive drug classes to choose from, each with its own risks and side effects. For those requiring a medication for control, this study suggests there may be an associated risk of breast cancer in postmenopausal women taking calcium channel blockers for a long duration.

Eating Walnuts Extends Longevity

By Mona Morstein, ND
Nut consumption was associated with a significantly reduced risk of all-cause mortality. Compared to non-consumers, subjects consuming nuts >3 servings/week had a 39% lower mortality risk. A similar protective effect against cardiovascular and cancer mortality was observed.

The Problem With Estrogen Metabolite Ratios

By Jacob Schor, ND, FABNO
The theory that estrogen metabolite ratios are predictive of cancer risk is failing in these studies to be predictive. This current paper is one more in a series that call this hypothesis into question. It may be time for our profession to reassess the theory and rethink the clinical practices we have adopted based on these assumptions.

Healthcare Perspectives

Does Resveratrol Blunt the Benefits of Exercise?

By NMJ Contributors
We now know that minute quantities of reactive oxygen species are essential to life, and that high levels are detrimental. The concept that nutrients also have doses that are beneficial, beyond which they are detrimental, is in keeping with the idea that optimal physiological function is a balance within the cells and the organism as a whole.

Peer-Reviewed Articles

Preventive Cardiology

By Stephen W. Parcell, ND
The current standard of care does not include detection of asymptomatic atherosclerosis. Instead, traditional risk factors are evaluated, the patient is put into a low-, medium-, or high-risk category, and lipid targets are determined by the clinician depending on the category. Thus, coronary artery disease is not detected early. We know that early detection of cancer saves lives. The same is true for atherosclerosis.

Interviews with Experts

The Use of Digestive Enzymes in Specific Digestive Disorders

By M. Mamadou, PhD
As a companion piece to our Q&A with M Mamadou, PhD, in the September 2013 NMJ Supplement, we asked Dr Mamadou to outline some specific digestive orders that can benefit from the use of supplemental digestive enzymes.

Special Thanks to Our Key Sponsors